Trial Profile
A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic retinopathy
- Focus Expanded access; Therapeutic Use
- Acronyms GUARDIAN
- 09 Dec 2011 New trial record